Drugmaker Pfizer has agreed to lower drug costs under a deal struck with President Donald Trump's administration. Trump made the announcement Tuesday with Pfizer CEO Albert Bourla at the White House. Under the agreement, New York-based Pfizer will charge most-favored-nation pricing to Medicaid and guarantee the same pricing on newly launched drugs. That involves matching the lowest price offered in other developed nations. The agreement by Pfizfer builds on an executive order Trump signed in May setting a deadline for drugmakers to electively lower prices or face new limits on what the government will pay.

Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it …

WASHINGTON (AP) — The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today's most common omicro…

WASHINGTON (AP) — U.S. regulators said Friday they are no longer considering authorizing a second COVID-19 booster shot for all adults under 5…

U.S. regulators on Friday authorized the first COVID-19 shots for infants and preschoolers, paving the way for vaccinations to begin next week.

COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.

Parents anxious to finally vaccinate their youngest children against COVID-19, strap in: A lot is set to happen over the next week.

Americans 50 and older can get a second COVID-19 booster if it's been at least four months since their last vaccination, a chance at extra pro…

WASHINGTON (AP) — Drugmaker Pfizer is expected to request authorization this week for an additional COVID-19 booster dose for seniors, accordi…

WASHINGTON (AP) — U.S. regulators on Friday put the brakes on their push to speed Pfizer's COVID-19 vaccine to children under 5, creating majo…